Catalase overexpression prevents hypertension and tubular apoptosis in angiotensinogen transgenic mice

Nicolas Godin(Hotel Dieu Hospital), Fang Liu(Hotel Dieu Hospital), Garnet Lau(Hotel Dieu Hospital), Marie-Luise Brezniceanu(Hotel Dieu Hospital), Isabelle Chénier(Hotel Dieu Hospital), János G. Filep(Hôpital Maisonneuve-Rosemont), Julie R. Ingelfinger(Harvard University), Shao‐Ling Zhang(Hotel Dieu Hospital), John S.D. Chan(Hotel Dieu Hospital)
Kidney International
March 17, 2010
10.1038/ki.2010.63
Cited by 87Open Access
Full Text

Abstract

Related Papers

[Commentary to the article: ONTARGET Investigators, Yusuf S, Teo KK, Pogue J et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008; 358: 1547-59].
Marcin Dominiak|PubMed|2008|581
Characterization of Renal Angiotensin-Converting Enzyme 2 in Diabetic Nephropathy
Christos Tikellis, Colin I. Johnston, Josephine M. Forbes et al.|Hypertension|2003|355
Suppression of Doxorubicin Cardiotoxicity by Overexpression of Catalase in the Heart of Transgenic Mice
Y. James Kang, Yan Chen, Paul N. Epstein|Journal of Biological Chemistry|1996|303
Angiotensin II Up-Regulates Angiotensin I-Converting Enzyme (ACE), but Down-Regulates ACE2 via the AT1-ERK/p38 MAP Kinase Pathway
Vijay Koka, Xiao Ru Huang, Arthur C.K. Chung et al.|American Journal Of Pathology|2008|282
Decreased glomerular and tubular expression of ACE2 in patients with type 2 diabetes and kidney disease
Heather N. Reich, Gavin Y. Oudit, Josef Penninger et al.|Kidney International|2008|259